Safety, Tolerability and Pharmacokinetics of ONC1-0013B in Patients With Progressive Metastatic Castration-resistant Prostate Cancer
NCT03074032
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Interventions
DRUG:
ONC1-0013B
Sponsor
Avionco LLC